The Effects of Intelectin-1 on Antioxidant and Angiogenesis in HUVECs Exposed to Oxygen Glucose Deprivation

Ischemic stroke leads to cellular death and tissue damage by depriving the areas of glucose and oxygen supplies. The effective treatment of stroke remains a challenge for modern medicine. This study used an oxygen-glucose deprivation (OGD) model of human umbilical vein endothelial cells (HUVECs) to...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in neurology Vol. 10; p. 383
Main Authors Gu, Naibing, Wang, Jun, Di, Zhengli, Liu, Zhiqin, Jia, Xiaotao, Yan, Yu'e, Chen, Xiaoshan, Zhang, Quanzeng, Qian, Yihua
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 16.04.2019
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Ischemic stroke leads to cellular death and tissue damage by depriving the areas of glucose and oxygen supplies. The effective treatment of stroke remains a challenge for modern medicine. This study used an oxygen-glucose deprivation (OGD) model of human umbilical vein endothelial cells (HUVECs) to mimic ischemic injuries and explored the role and mechanism of intelectin-1. Intelectin-1 was transduced into the HUVECs using a lentiviral vector. The PI3K/Akt signaling was examined in intelectin-induced eNOS phosphorylation. The PI3K inhibitor LY294002 was dealed in HUVECs. Our results demonstrated an increase in capillary density, decrease in apoptotic cells, and increase in HIF-1α protein expression following intelectin-1 treatment. Real-time PCR and Western blotting revealed the increased intelectin-1 expression alongside eNOS and Akt phosphorylation with enhanced bcl-2 expression under OGD. Capillary density decreased significantly after LY294002 treatment. These results suggest intelectin-1 promotes angiogenesis, inhibits oxidative stress and reduces apoptosis by stimulating the Akt-eNOS signaling pathway in response to ischemia .
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Edited by: Milena De Felice, University of Sheffield, United Kingdom
This article was submitted to Headache Medicine and Facial Pain, a section of the journal Frontiers in Neurology
Reviewed by: Ali Sazci, Kocaeli University, Turkey; Guiqiong He, Chongqing Medical University, China
Co-first authors
ISSN:1664-2295
1664-2295
DOI:10.3389/fneur.2019.00383